Table 3.
Indication | Dose (by mouth) | Gender | Pregnancy category |
---|---|---|---|
Chronic idiopathic constipation | 24 µg twice daily | Male and female | C |
Irritable bowel syndrome with constipation | 8 µg twice daily | Female | C |
Opioid-induced constipation | 24 µg twice daily | Male and Female | C |